David Busquets

Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes

Mireia López‐Siles, Margarita Martínez-Medina, David Busquets et al. · International Journal of Medical Microbiology · 2014 · 172 citations

Life Sciences, Immunology, Microbiology +16

Mucosa-Associated Faecalibacterium prausnitzii Phylotype Richness Is Reduced in Patients with Inflammatory Bowel Disease

Mireia López‐Siles, Margarita Martínez-Medina, C. A. Abella et al. · Applied and Environmental Microbiology · 2015 · 118 citations · Full text

Life Sciences, Microbiology, Pathology +17

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study

María José Casanova, María Chaparro, Valle García–Sánchez et al. · The American Journal of Gastroenterology · 2016 · 112 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry

María Chaparro, A Garre, Francisco Mesonero et al. · Journal of Crohn s and Colitis · 2020 · 102 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

María Chaparro, A Garre, Marisa Iborra et al. · Journal of Crohn s and Colitis · 2021 · 81 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15